Motivations for new psychoactive substance use among regular psychostimulant users in Australia
- 1 May 2017
- journal article
- research article
- Published by Elsevier in International Journal of Drug Policy
- Vol. 43, 23-32
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Synthetic cannabinoid use among patients in residential substance use disorder treatment: Prevalence, motives, and correlatesDrug and Alcohol Dependence, 2014
- “PMA Sounds Fun”: Negotiating Drug Discourses OnlineSubstance Use & Misuse, 2014
- A Survey of Synthetic Cannabinoid Consumption by Current Cannabis UsersSubstance Abuse, 2014
- The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sampleJournal of Psychopharmacology, 2014
- Kronic hysteria: Exploring the intersection between Australian synthetic cannabis legislation, the media, and drug-related harmInternational Journal of Drug Policy, 2013
- Do Novel Psychoactive Substances Displace Established Club Drugs, Supplement Them or Act as Drugs of Initiation? The relationship between Mephedrone, Ecstasy and CocaineEuropean Addiction Research, 2013
- Patterns of synthetic cannabinoid use in AustraliaDrug and Alcohol Review, 2012
- Instability of the ecstasy market and a new kid on the block: mephedroneJournal of Psychopharmacology, 2010
- Dimethyltryptamine (DMT): Subjective effects and patterns of use among Australian recreational usersDrug and Alcohol Dependence, 2010
- Self-report among injecting drug users: A reviewDrug and Alcohol Dependence, 1998